{"id":"https://openalex.org/A5092123133","orcid":"https://orcid.org/0009-0000-0090-2459","observed_orcids":["https://orcid.org/0009-0000-0090-2459"],"display_name":"Vasilisa A. Sukhanova","raw_author_names":["Vasilisa A. Sukhanova","Vasilisa Sukhanova"],"full_name":"Vasilisa A. Sukhanova","works_count":3,"cited_by_count":7,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":2,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5092123133","orcid":"https://orcid.org/0009-0000-0090-2459","observed_orcids":["https://orcid.org/0009-0000-0090-2459"]},"affiliations":[{"institution":{"id":"https://openalex.org/I126527374","ror":"https://ror.org/02dn9h927","display_name":"Peoples' Friendship University of Russia","country_code":"RU","type":"education","lineage":["https://openalex.org/I126527374"]},"years":[2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I126527374","ror":"https://ror.org/02dn9h927","display_name":"Peoples' Friendship University of Russia","country_code":"RU","type":"education","lineage":["https://openalex.org/I126527374"]}],"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":1,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","count":1,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","count":1,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","count":1,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","value":1.22e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","value":1.06e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12282","display_name":"Mineral Processing and Grinding","value":5.6e-06,"subfield":{"id":"https://openalex.org/subfields/2210","display_name":"Mechanical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","value":5.2e-06,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","score":0.5012845993041992},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.44250404834747314},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.35997387766838074},{"id":"104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","score":0.08078280091285706},{"id":"10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","score":0.0}],"counts_by_year":[{"year":2023,"works_count":2,"oa_works_count":2,"cited_by_count":1},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":2},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":1}],"display_name_alternatives":["Vasilisa A. Sukhanova","Vasilisa Sukhanova"],"block_key":"v sukhanova","works_api_url":"https://api.openalex.org/works?filter=author.id:A5092123133","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5092123133","updated_date":"2026-11-13T15:08:24","created_date":"2023-06-10T00:00:00"}
